Sarepta Therapeutics Inc (SRPT)

Stock price, financials, and technical signals for Sarepta Therapeutics Inc (SRPT).

Twitter
Facebook
Email
FinancialsNews & SentimentProCandlestick ProbabilityElite

$127.95

-5.39

(-4.04%)

As of 12/02/2024 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

SRPT Performance Snapshot


1-Week Chg

11.60%

1-Month Chg

3.78%

3-Month Chg

-5.77%

6-Month Chg

-1.47%

1-Year Chg

51.53%

Year-To-Date Chg

32.99%

Beta 1-Year

1.38

Beta 5-Year

0.72

Volatility (10-Day)

9.63%

SRPT Technicals



SRPT Financials


Balance Sheet

(USD)

PERIOD

Y/Y CHANGE


  • Cash and equivalents

    -

    -

  • Total assets

    -

    -

  • Total liabilities

    -

    -

  • Total investments

    -

    -

  • Shareholders' equity

    -

    -

  • Book value per share

    -

    -


Income Statement

(USD)

PERIOD

Y/Y CHANGE


  • Revenue

    -

    -

  • Net income

    -

    -

  • Operating expense

    -

    -

  • Gross profit

    -

    -

  • EBITDA

    -

    -

  • Earnings per share

    -

    -


Cash Flow

(USD)

PERIOD

Y/Y CHANGE


  • Net change in cash

    -

    -

  • Cash from operations

    -

    -

  • Cash from investing

    -

    -

  • Cash from financing

    -

    -

  • Free cash flow

    -

    -

  • Free cash flow per share

    -

    -


Metrics

(USD)

PERIOD

Y/Y CHANGE


  • Market capitalization

    -

    -

  • Enterprise value

    -

    -

  • Shares outstanding

    -

    -

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

PERIOD

Y/Y CHANGE


  • Dividend yield

    -

    -

  • Dividends per share

    -

    -

  • Dividend growth

    -

    -

  • Payout ratio

    -

    -

  • Coverage ratio

    -

    -

  • Current ratio

    -

    -


View All Financials

Dream big, trade smart: empowering retail stock traders and investors.

Newsletter

Get weekly swing trade stock picks, published by The Swing.

Platform

Company

Copyright © 2024 Stocksift LLC

Made with in St. Louis

Financial information is not financial advice, read our disclaimers.